Panacea Biotec Management
Management criteria checks 2/4
Panacea Biotec's CEO is Rajesh Jain, appointed in Feb 2002, has a tenure of 22.17 years. total yearly compensation is ₹8.24M, comprised of 72.8% salary and 27.2% bonuses, including company stock and options. directly owns 49.33% of the company’s shares, worth ₹4.34B. The average tenure of the management team and the board of directors is 8.9 years and 8 years respectively.
Key information
Rajesh Jain
Chief executive officer
₹8.2m
Total compensation
| CEO salary percentage | 72.8% |
| CEO tenure | 22.2yrs |
| CEO ownership | 49.3% |
| Management average tenure | 8.9yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -₹117m |
| Sep 30 2023 | n/a | n/a | ₹99m |
| Jun 30 2023 | n/a | n/a | ₹334m |
| Mar 31 2023 | ₹8m | ₹6m | -₹332m |
| Dec 31 2022 | n/a | n/a | ₹12b |
| Sep 30 2022 | n/a | n/a | ₹11b |
| Jun 30 2022 | n/a | n/a | ₹11b |
| Mar 31 2022 | ₹8m | ₹6m | ₹11b |
| Dec 31 2021 | n/a | n/a | -₹2b |
| Sep 30 2021 | n/a | n/a | -₹2b |
| Jun 30 2021 | n/a | n/a | -₹2b |
| Mar 31 2021 | ₹7m | ₹6m | -₹1b |
| Dec 31 2020 | n/a | n/a | -₹2b |
| Sep 30 2020 | n/a | n/a | -₹1b |
| Jun 30 2020 | n/a | n/a | -₹2b |
| Mar 31 2020 | ₹8m | ₹6m | -₹2b |
| Dec 31 2019 | n/a | n/a | ₹653m |
| Sep 30 2019 | n/a | n/a | ₹715m |
| Jun 30 2019 | n/a | n/a | ₹482m |
| Mar 31 2019 | ₹7m | ₹6m | ₹410m |
| Mar 31 2018 | ₹7m | ₹6m | -₹716m |
Compensation vs Market: Rajesh's total compensation ($USD98.81K) is above average for companies of similar size in the Indian market ($USD39.29K).
Compensation vs Earnings: Rajesh's compensation has increased whilst the company is unprofitable.
CEO
Rajesh Jain (59 yo)
22.2yrs
Tenure
₹8,240,000
Compensation
Dr. Rajesh Jain, Ph D has been Managing Director at Panacea Biotec Limited since March 12, 2018 and serves as its Whole-Time Director and serves as its Chairman of the Board at Panacea Biotec Limited since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & MD | 22.2yrs | ₹8.24m | 49.33% ₹ 4.3b | |
| Joint MD & Executive Director | 22.2yrs | ₹7.56m | 16.38% ₹ 1.4b | |
| CFO & Head of Information Technology | 8.9yrs | ₹5.59m | no data | |
| Chief Scientific Officer | no data | ₹6.26m | no data | |
| Group CFO | 8.9yrs | ₹6.78m | no data | |
| Director of Sales & Marketing and Whole-Time Director | 8yrs | ₹2.93m | no data | |
| Sr. Vice President - Business Development & Corporate Affairs | no data | ₹5.08m | no data | |
| Vice President of Corporate Quality Assurance | no data | ₹6.00m | no data | |
| VP of Clinical Research | no data | ₹5.20m | no data | |
| Chief Operating Officer | 4.4yrs | no data | no data | |
| General Manager of Accounts & Taxation | no data | no data | no data | |
| Senior Vice President of Pharma Research & Pharma Regulatory Affairs | 4.4yrs | no data | no data |
8.9yrs
Average Tenure
56yo
Average Age
Experienced Management: 531349's management team is seasoned and experienced (8.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & MD | 39.4yrs | ₹8.24m | 49.33% ₹ 4.3b | |
| Joint MD & Executive Director | 39.4yrs | ₹7.56m | 16.38% ₹ 1.4b | |
| Director of Sales & Marketing and Whole-Time Director | 8yrs | ₹2.93m | no data | |
| Additional Non-Executive Non-Independent Director | 2yrs | ₹200.00k | no data | |
| Non-Executive Independent Director | 9.1yrs | ₹200.00k | no data | |
| Non-Executive Independent Director | 8yrs | ₹200.00k | no data | |
| Non-Executive Independent Director | no data | no data | no data |
8.0yrs
Average Tenure
62yo
Average Age
Experienced Board: 531349's board of directors are considered experienced (8 years average tenure).